solid tumours
Rubius launches $200m IPO to fund red blood cell therapies
Richard Staines
acute myeloid leukaemia, cancer, immunology, IPO, solid tumours
0 Comment
X
Rubius launches $200m IPO to fund red blood cell therapies
https://pharmaphorum.com/news/rubius-launches-200m-ipo-for-red-blood-cell-therapies/
Catamaran joins the CAR-NK fleet, raising $42m in first round
Phil Taylor
Biotech, blood cancers, car-nk, Catamaran Bio, cell therapy, immuno-oncology, Oncology, solid tumours
0 Comment
X
Catamaran joins the CAR-NK fleet, raising $42m in first round
https://pharmaphorum.com/news/catamaran-joins-the-car-nk-fleet-raising-42m-in-first-round/
ADC Therapeutics sets terms for $125m IPO
Richard Staines
ADC Therapeutics, blood cancer, cancer, DLBCL, IPO, lymphoma, Oncology, solid tumours
0 Comment
X
ADC Therapeutics sets terms for $125m IPO
https://pharmaphorum.com/news/adc-therapeutics-sets-terms-for-125m-ipo/